WAT · Waters Corp /De/
Market Cap
$40.63B
Shares
98.25M
WAT metrics
79 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$409.38
Market cap
$40.63B
Price action
19 metricsPrice change (1W)
-1.8%
Price change (30D)
+3.5%
Price change (3M)
+9.9%
Price change (6M)
+31.0%
Price change (YTD)
+8.9%
Price change (1Y)
+42.6%
Trailing year
Price change (5Y)
-2.3%
52-week high
$421.26
52-week low
$283.32
Change from 52-week high
-1.8%
Change from 52-week low
+46.0%
Annualized volatility
36.2%
Beta
0.9
RSI (14D)
57.0
Price vs SMA 50
+5.8%
Price vs SMA 200
+14.7%
Avg volume (3M)
845,705
Relative volume
0.5
Average dollar volume
$323.89M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
98.25M
Valuation
12 metricsP / E (TTM)
103.1
Trailing earnings · reciprocal yield 1.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.7×
reciprocal yield 11.4%
P / book
2.7
reciprocal yield 37.4%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
73.9
reciprocal yield 1.4%
Earnings yield
0.4%
Historical valuation
8 metricsP / E historical average (3Y)
30.2×
reciprocal yield 3.3%
P / E historical average (5Y)
30.6×
reciprocal yield 3.3%
EV / revenue historical average (3Y)
7.5×
reciprocal yield 13.4%
EV / revenue historical average (5Y)
7.3×
reciprocal yield 13.7%
EV / EBIT historical average (3Y)
42.0×
reciprocal yield 2.4%
EV / EBIT historical average (5Y)
36.6×
reciprocal yield 2.7%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-04
Profitability
9 metricsGross margin
—
Operating margin
7.1%
Trailing 12 months
Net margin
20.3%
Gross profit (TTM)
$1.23B
Operating profit (TTM)
$329.63M
Net income (TTM)
$166.63M
Trailing 12 months
Diluted EPS (TTM)
$4.01
FCF margin
—
Effective tax rate
19.1%
Growth
11 metricsRevenue growth YoY
+113.3%
Year over year
Net income growth YoY
-192.5%
Revenue (TTM)
$4.64B
Trailing 12 months
EPS growth YoY
-156.3%
Shares change YoY
+164,517.1%
Year over year · more shares
Revenue CAGR (3Y)
+2.1%
Revenue CAGR (5Y)
+6.0%
EPS CAGR (3Y)
-2.8%
EPS CAGR (5Y)
+5.2%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
1.1%
Return on assets
0.7%
Debt / equity
—
Current ratio
1.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
2.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$539.00M
Total assets
$24.75B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$549.55M
Capital expenditures (TTM)
—
R&D (TTM)
$318.54M
SG&A (TTM)
$1.25B
Stock compensation (TTM)
$73.13M
R&D / revenue
6.9%
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
1,180
13F filer change QoQ
+1
Institutional ownership
100.1%
Short interest
3 metricsShort interest
3.7%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
55 / 100
Insider activity
2 metricsNet insider buying (90D)
−$1.44M
Insider-sentiment score
44 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1000697
CUSIP
941848103
13F (30d)
673 filings
633 filers
Visit website
Investor relations